Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02089126
What this trial is testing

Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
LG Life Sciences 230
Testing effectiveness (Phase 2)Ended earlyNCT03152552
What this trial is testing

A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure

Who this might be right for
Diabetes Mellitus and Heart Failure
Novartis Pharmaceuticals 125
Early research (Phase 1)Study completedNCT00806338
What this trial is testing

An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

Who this might be right for
Diabetes MellitusObesity
Genaera Corporation 22
Post-approval studies (Phase 4)Study completedNCT01897532
What this trial is testing

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 6,991
Not applicableLooking for participantsNCT07440147
What this trial is testing

Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers

Who this might be right for
Obesity & OverweightCircadian Rhythm DisordersGut Microbiota Modulation+1 more
FH Joanneum Gesellschaft mbH 200
Large-scale testing (Phase 3)UnknownNCT03421119
What this trial is testing

Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Cinnagen 300
Large-scale testing (Phase 3)Study completedNCT01610934
What this trial is testing

The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)

Who this might be right for
Maturity-onset Diabetes of the Young
University Hospital, Gentofte, Copenhagen 15
Early research (Phase 1)Study completedNCT01177163
What this trial is testing

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 29
Early research (Phase 1)Study completedNCT06279234
What this trial is testing

Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Obesity
Pfizer 50
Testing effectiveness (Phase 2)Study completedNCT03664921
What this trial is testing

Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy

Who this might be right for
Diabetic NeuropathiesNeuropathic PainPain, Chronic
Syntrix Biosystems, Inc. 55
Early research (Phase 1)Looking for participantsNCT07570992
What this trial is testing

A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DM

Who this might be right for
Healthy VolunteersDiabetes Mellitus, Type 2
Novo Nordisk A/S 58
Testing effectiveness (Phase 2)Study completedNCT01445899
What this trial is testing

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Who this might be right for
Choroidal NeovascularizationDiabetic RetinopathyDiabetic Macular Edema
Quark Pharmaceuticals 258
Large-scale testing (Phase 3)Active Not RecruitingNCT06531512
What this trial is testing

Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Ulcer
Oneness Biotech Co., Ltd. 120
Testing effectiveness (Phase 2)Ended earlyNCT05177107
What this trial is testing

Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

Who this might be right for
OsteomyelitisDiabetic Foot Osteomyelitis
Adaptive Phage Therapeutics, Inc. 41
Testing effectiveness (Phase 2)Study completedNCT03238963
What this trial is testing

A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.

Who this might be right for
Diabetic Retinopathy
Boehringer Ingelheim 79
Testing effectiveness (Phase 2)Ended earlyNCT00263965
What this trial is testing

ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity

Who this might be right for
Type 2 Diabetes
AstraZeneca 105
Large-scale testing (Phase 3)Study completedNCT00666458
What this trial is testing

18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)

Who this might be right for
Type 2 Diabetes
AstraZeneca 822
Large-scale testing (Phase 3)Study completedNCT01134107
What this trial is testing

Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 133
Not applicableUnknownNCT06114134
What this trial is testing

The Effects of Fenugreek Extract (Fenobet) on Metabolic Syndrome

Who this might be right for
Metabolic SyndromeComplementary TherapiesDiabetes Mellitus, Type 2
Tehran University of Medical Sciences 60
Early research (Phase 1)Looking for participantsNCT07590193
What this trial is testing

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Amgen 162
Next Page